There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for MiMedx Group Inc. (MDXG) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.03, or 0.38%, to $7.97. The MiMedx Group Inc. has recorded 18,659 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed MIMEDX to Present at Upcoming Investor Conferences.
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $7.94 and fluctuated between $7.97 as its day high and $7.61 as its day low. The current market capitalization of MiMedx Group Inc. is $888.17M. A total of 0.52 million shares were traded on the day, compared to an average of 834.35K shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, MDXG has seen 10 BUY and 0 SELL insider trades, representing the acquisition of 444,678 and the disposition of 0 shares. Over the last 12 months, there were 16 BUYs and 25 SELLs from insiders. Insiders purchased 1,572,449 shares during that period but sold 235,649.
In the most recent transaction, Stein Robert Benjamin sold 10,365 shares of MDXG for 5.95 per share on May 16. After the transaction, the President, Regenerative Med. now owns 317,803 company shares. In a previous transaction on May 15, Stein Robert Benjamin sold 3,607 shares at 6.15 per share. MDXG shares that President, Regenerative Med. owns now total 328,168.
Among the insiders who sold shares, Carlson Peter M disposed of 5,976 shares on May 10 at a per-share price of $5.93. This resulted in the Chief Financial Officer holding 656,435 shares of MDXG after the transaction. In another insider transaction, Hulse William Frank IV sold 5,870 shares at $5.93 per share on May 10. Company shares held by the General Counsel and CAO now total 456,564.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for MDXG in the last 3 months, the mean price target is $12.06 with high estimates of $14.00 and low estimates of $11.00. In terms of 52-week highs and lows, MDXG has a high of $8.60 and a low of $2.43.
As of this writing, MDXG has an earnings estimate of $0.04 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of $0.05 per share and a lower estimate of $0.04. The company reported an EPS of -$0.06 in the last quarter, which was 33.30% higher than expectations of -$0.09.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. MDXG’s latest balance sheet shows that the firm has $87.08M in Cash & Short Term Investments as of fiscal 2021. There were $48.13M in debt and $42.36M in liabilities at the time. Its Book Value Per Share was -$0.11, while its Total Shareholder’s Equity was $82.00k.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MDXG is Buy with a score of 5.00.